Garzulys
NDC 71288-904, insulin aspart-fsan, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-904
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761497
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-904 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN ASPART100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-904-10 | 71288090410 | 1 VIAL, GLASS in 1 CARTON (71288-904-10) / 10 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/30c64769-d2f7-4604-ac9e-2a6bc09506c9
Use it
Look up 71288-904 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-904 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-904. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.